Predicting progression of Alzheimer's disease using forward-to-backward bi-directional network with integrative imputation.
Alzheimer’s progression
Clinical status prediction
MRI biomarker forecasting
Missing value imputation
Progressive recurrent networks
Journal
Neural networks : the official journal of the International Neural Network Society
ISSN: 1879-2782
Titre abrégé: Neural Netw
Pays: United States
ID NLM: 8805018
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
03
08
2021
revised:
23
02
2022
accepted:
10
03
2022
pubmed:
2
4
2022
medline:
14
4
2022
entrez:
1
4
2022
Statut:
ppublish
Résumé
If left untreated, Alzheimer's disease (AD) is a leading cause of slowly progressive dementia. Therefore, it is critical to detect AD to prevent its progression. In this study, we propose a bidirectional progressive recurrent network with imputation (BiPro) that uses longitudinal data, including patient demographics and biomarkers of magnetic resonance imaging (MRI), to forecast clinical diagnoses and phenotypic measurements at multiple timepoints. To compensate for missing observations in the longitudinal data, we use an imputation module to inspect both temporal and multivariate relations associated with the mean and forward relations inherent in the time series data. To encode the imputed information, we define a modification of the long short-term memory (LSTM) cell by using a progressive module to compute the progression score of each biomarker between the given timepoint and the baseline through a negative exponential function. These features are used for the prediction task. The proposed system is an end-to-end deep recurrent network that can accomplish multiple tasks at the same time, including (1) imputing missing values, (2) forecasting phenotypic measurements, and (3) predicting the clinical status of a patient based on longitudinal data. We experimented on 1,335 participants from The Alzheimer's Disease Prediction of Longitudinal Evolution (TADPOLE) challenge cohort. The proposed method achieved a mean area under the receiver-operating characteristic curve (mAUC) of 78% for predicting the clinical status of patients, a mean absolute error (MAE) of 3.5ml for forecasting MRI biomarkers, and an MAE of 6.9ml for missing value imputation. The results confirm that our proposed model outperforms prevalent approaches, and can be used to minimize the progression of Alzheimer's disease.
Identifiants
pubmed: 35364417
pii: S0893-6080(22)00094-6
doi: 10.1016/j.neunet.2022.03.016
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
422-439Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.